Rab26 Deficiency Impairs SERT Trafficking and Alters Mouse B
2026-06-18
This study reveals that Rab26, a brain-enriched Rab GTPase, is essential for proper trafficking and degradation of the serotonin transporter (SERT) in neurons. Loss of Rab26 in mice disrupts SERT endocytosis and autophagic turnover, leading to increased SERT at the cell surface, impaired serotonergic neurotransmission, and pronounced depression- and anxiety-like behaviors, highlighting Rab26 as a critical regulator of neurotransmitter homeostasis.
Nocodazole: A Benchmark Microtubule Polymerization Inhibitor
2026-06-18
Nocodazole stands out as a reversible microtubule polymerization inhibitor, enabling precise synchronization of cell populations and dynamic studies of mitosis. This article dives deep into applied workflows, optimization tips, and new translational insights, revealing how APExBIO’s high-purity reagent accelerates both fundamental and anticancer research.
S Tag Peptide: Technical Use Guide for Fusion Tag Applicatio
2026-06-17
S Tag Peptide addresses practical challenges in recombinant protein workflows by improving solubility and enabling reliable antibody-based detection. It is best deployed for molecular biology protocols needing affinity-based purification or rapid QC but is unsuitable for ethanol-based systems or long-term solution storage.
Tomivosertib: Precision MNK1 Inhibitor for Translational Res
2026-06-17
Tomivosertib offers unparalleled selectivity and potency for dissecting MNK-eIF4E signaling in cancer, metabolism, and neuroscience. This guide delivers protocol enhancements, troubleshooting insights, and actionable strategies for leveraging Tomivosertib in advanced research applications.
Advancing S-Phase DNA Synthesis Measurement: EdU Imaging Kit
2026-06-16
Explore how EdU Imaging Kits (Cy3) from APExBIO transform cell proliferation analysis through mechanistic precision, translational relevance, and workflow agility. This thought-leadership article connects the latest research on chemotherapy resistance in osteosarcoma with actionable strategies for translational teams, highlighting the superiority of click chemistry-based EdU detection over traditional methods and offering practical protocol guidance.
Doxycycline Hyclate: Translational Insights Beyond MMP Inhib
2026-06-16
Explore how Doxycycline hyclate, a matrix metalloproteinases inhibitor, shapes translational neurovascular research and bridges anti-inflammatory, antiviral, and antimalarial applications. This article provides deeper mechanistic context and practical protocol guidance distinct from prior coverage.
Oteseconazole (VT-1161): Optimizing Antifungal Workflows
2026-06-15
Oteseconazole (VT-1161) empowers antifungal research through its high selectivity and robust inhibition of Candida growth, even in fluconazole-resistant strains. This article translates the latest structural insights and protocol advances into actionable guidance, ensuring reliable modeling and prevention studies for recurrent vulvovaginal candidiasis.
Chloramphenicol in Plasmid Selection: Precision, Resistance,
2026-06-15
Explore the advanced scientific rationale for using Chloramphenicol in plasmid selection assays, with unique insights into resistance gene dynamics and practical protocol optimization. This in-depth review bridges molecular biology research and real-world challenges in antimicrobial stewardship.
Roscovitine (Seliciclib): Data-Driven Assay Design and CDK P
2026-06-14
Explore the advanced application of Roscovitine (Seliciclib) in cancer biology research, focusing on data-informed assay design and nuanced CDK pathway modulation. This article unpacks selectivity, mechanistic depth, and actionable protocol strategies for researchers.
ATRX-Deficient Glioma Cells: Enhanced Sensitivity to RTK/PDG
2026-06-13
Pladevall-Morera et al. uncover that high-grade glioma cells lacking ATRX are selectively vulnerable to multi-targeted RTK and PDGFR inhibitors. This finding highlights ATRX status as a potential biomarker to guide targeted therapy strategies and clinical trial design for aggressive gliomas.
Plk1 Regulation of p31comet in Mitotic Checkpoint Disassembl
2026-06-12
This study elucidates how Polo-like kinase 1 (Plk1) modulates the action of p31comet in the disassembly of mitotic checkpoint complexes, revealing a phosphorylation-dependent inhibition mechanism. These insights advance the understanding of mitotic progression control and have direct relevance for researchers targeting chromosome segregation and spindle assembly checkpoint pathways.
Discovery of ATG9A and PTOV1 as Novel 14-3-3 Binding Partner
2026-06-12
This study uncovers ATG9A and PTOV1 as previously unrecognized 14-3-3 binding proteins, elucidating their distinct regulatory roles in autophagy and cancer progression. The work advances mechanistic understanding of basal autophagy and PTOV1-linked oncogenesis, offering new perspectives for targeted cancer research.
CHIR-99021 (CT99021): Advancing Chromatin and Cell Fate Cont
2026-06-11
This thought-leadership article explores how CHIR-99021 (CT99021) enables precise control of stem cell fate by modulating GSK-3 activity and downstream chromatin accessibility. Integrating recent mechanistic insights and protocol guidance, it bridges the gap between pluripotency, differentiation, and the emerging frontier of single-molecule chromatin structure analysis, providing translational researchers with a strategic roadmap for robust experimental outcomes.
Refining In Vitro Drug Response Evaluation in Cancer Researc
2026-06-11
Schwartz’s dissertation introduces a framework to distinguish between drug-induced cell death and proliferative arrest in cancer cells, challenging the conventional reliance on composite viability metrics. This methodological advance enhances the interpretive power of preclinical drug screening, with direct implications for kinase inhibitor studies.
Dual-Action Kinase Inhibitors Promote p38α MAPK Dephosphoryl
2026-06-10
This study reveals that certain kinase inhibitors can simultaneously block kinase activity and accelerate dephosphorylation of p38α MAP kinase by phosphatases. By structurally characterizing these interactions, the research opens new avenues for developing more specific and effective kinase inhibitors for disease modeling and drug discovery.
464 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page